by TractManager | Jul 11, 2023 | Health Technology Assessment
Focus of Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of fractional laser treatment (FLT) for functional improvement in patients with hypertrophic and keloid burn and traumatic scars.Technology Description: Laser...
by TractManager | Jul 10, 2023 | Emerging Technology Report
Lecanemab (Leqembi; Esai Co. Ltd. and Biogen) is an intravenously administered anti-amyloid beta (Aβ) protofibril antibody indicated for the treatment of Alzheimer disease. If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Jul 3, 2023 | Emerging Technology Report
Valoctocogene roxaparvovec (Roctavian; Biomarin Pharmaceutical Inc.) is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity < 1 international...
Recent Comments